Drug Overview: Trasylol Side Effects and Claims
Trasylol, manufactured by Bayer Pharmaceuticals, is an antifibrinolytic agent used during coronary artery bypass graft (CBAG) surgery. The main Trasylol claim is that it limits the loss of blood during surgery. The active ingredient in Trasylol is Aprotinin Bovine and the drug is administered via injection. It was approved by the FDA in December 1993, and has been in use on the market for 13 years.
Suffered harm from Trayslol? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.
The Food and Drug Administration (FDA) has issued a Trasylol warning as a result of a recent study in the New England Journal of Medicine finding evidence of serious Trasylol side effects. See Trasylol Information and Updates for important information about the safety of this drug.
Check out the following articles for more information about Trasylol, filing a Trasylol lawsuit and finding a Trasylol attorney.
Suffered harm from Trayslol? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights. | 
State Law Center | Legal Links | Site Map | Privacy Policy | Media | About Us | Contact Us